Femur length anomalies tend to decrease with later phenology (greater day of year of adulthood anomaly) regardless of elevation or species’ seasonal timing. حسب César R. Nufio (11646271)

The linearly decreasing convergence factor a. حسب Junhao Wei (6816803)

Average days (mean) to heal a wound in 2022 and 2023. حسب Heba Tallah Mohammed (2822432)

Mitigation (decreasing) scenario. حسب Fabio Correddu (12501799)

Predicting pattern diversity decreases as a function of and . حسب Selim Haj Ali (21222613)

"…(a) and (b): Average negative predictive value for and , respectively for and . …"

Claudin V is decreased following infection with Mtb. حسب Amanda S. Latham (12093638)

"…Representative images of the frontal cortex (A–D), cerebral nuclei (F–I), brain stem (K–N), thalamus (P–S), and hippocampus (U–X) 15 days post-infection are shown. …"

Pregnancy-induced decrease in maternal serum BUN and IFN- حسب Haruka Mizobuchi (5395394)

Sleep deprivation increased inflammatory cytokines and decreased corticosterone in the blood. حسب Weiran Shan (16969688)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. حسب Hakim Ben Abdallah (14578241)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. حسب Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). حسب Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... حسب Elizabeth S. Munroe (21568166)

Heteroscedastic linear mixed model main results, estimating the volume (ml) of beer sold per day on the transformed (cube root) scale, on the original scale and on the relative sca... حسب Eleni Mantzari (6991172)

الموضوعات:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. حسب Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. حسب Elizabeth S. Munroe (21568166)

Tetrandrine decreases Mtb antigen presentation. حسب Elham Karamooz (2584474)

Selection frequencies plotted in decreasing order. حسب Hannah P. Rowe (7830599)